Research progress on acupuncture treatment in central nervous system diseases based on NLRP3 inflammasome in animal models. 2023

Hai-Ming Zhang, and Dan Luo, and Rui Chen, and Shu-Han Wang, and Ya-Juan Zhao, and Jin-Xiao Li, and Min-Feng Zhou, and Zhao-Min Yu, and Jun-Li Zhang, and Feng-Xia Liang
College of Acupuncture-Moxibustion and Orthopedics, Hubei University of Chinese Medicine, Wuhan, China.

Central nervous system (CNS) disorders exhibit complex neurophysiological and pathological mechanisms, which seriously affect the quality of life in patients. Acupuncture, widely accepted as complementary and alternative medicine, has been proven to exert significant therapeutic effects on CNS diseases. As a part of the innate immune system, NLRP3 inflammasome contributes to the pathogenesis of CNS diseases via regulating neuroinflammation. To further explore the mechanisms of acupuncture regulating NLRP3 inflammasome in CNS diseases, our study focused on the effects of acupuncture on neuroinflammation and the NLRP3 inflammasome in vascular dementia, Alzheimer's disease, stroke, depression, and spinal cord injury. This study confirmed that the activation of NLRP3 inflammasome promotes the development of CNS diseases, and inhibiting the activation of NLRP3 inflammasome is a potential key target for the treatment of CNS diseases. In addition, it is concluded that acupuncture alleviates neuroinflammation by inhibiting the activation of the NLRP3 inflammasome pathway, thereby improving the progression of CNS diseases, which provides a theoretical basis for acupuncture to attenuate neuroinflammation and improve CNS diseases.

UI MeSH Term Description Entries

Related Publications

Hai-Ming Zhang, and Dan Luo, and Rui Chen, and Shu-Han Wang, and Ya-Juan Zhao, and Jin-Xiao Li, and Min-Feng Zhou, and Zhao-Min Yu, and Jun-Li Zhang, and Feng-Xia Liang
December 2013, Neuroscience bulletin,
Hai-Ming Zhang, and Dan Luo, and Rui Chen, and Shu-Han Wang, and Ya-Juan Zhao, and Jin-Xiao Li, and Min-Feng Zhou, and Zhao-Min Yu, and Jun-Li Zhang, and Feng-Xia Liang
October 2023, IUBMB life,
Hai-Ming Zhang, and Dan Luo, and Rui Chen, and Shu-Han Wang, and Ya-Juan Zhao, and Jin-Xiao Li, and Min-Feng Zhou, and Zhao-Min Yu, and Jun-Li Zhang, and Feng-Xia Liang
September 2019, CNS neuroscience & therapeutics,
Hai-Ming Zhang, and Dan Luo, and Rui Chen, and Shu-Han Wang, and Ya-Juan Zhao, and Jin-Xiao Li, and Min-Feng Zhou, and Zhao-Min Yu, and Jun-Li Zhang, and Feng-Xia Liang
April 2012, Sheng li ke xue jin zhan [Progress in physiology],
Hai-Ming Zhang, and Dan Luo, and Rui Chen, and Shu-Han Wang, and Ya-Juan Zhao, and Jin-Xiao Li, and Min-Feng Zhou, and Zhao-Min Yu, and Jun-Li Zhang, and Feng-Xia Liang
January 2024, Frontiers in cardiovascular medicine,
Hai-Ming Zhang, and Dan Luo, and Rui Chen, and Shu-Han Wang, and Ya-Juan Zhao, and Jin-Xiao Li, and Min-Feng Zhou, and Zhao-Min Yu, and Jun-Li Zhang, and Feng-Xia Liang
May 2018, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
Hai-Ming Zhang, and Dan Luo, and Rui Chen, and Shu-Han Wang, and Ya-Juan Zhao, and Jin-Xiao Li, and Min-Feng Zhou, and Zhao-Min Yu, and Jun-Li Zhang, and Feng-Xia Liang
January 2021, Frontiers in pharmacology,
Hai-Ming Zhang, and Dan Luo, and Rui Chen, and Shu-Han Wang, and Ya-Juan Zhao, and Jin-Xiao Li, and Min-Feng Zhou, and Zhao-Min Yu, and Jun-Li Zhang, and Feng-Xia Liang
November 2018, Cornea,
Hai-Ming Zhang, and Dan Luo, and Rui Chen, and Shu-Han Wang, and Ya-Juan Zhao, and Jin-Xiao Li, and Min-Feng Zhou, and Zhao-Min Yu, and Jun-Li Zhang, and Feng-Xia Liang
January 2016, Journal of immunology research,
Hai-Ming Zhang, and Dan Luo, and Rui Chen, and Shu-Han Wang, and Ya-Juan Zhao, and Jin-Xiao Li, and Min-Feng Zhou, and Zhao-Min Yu, and Jun-Li Zhang, and Feng-Xia Liang
January 2022, Frontiers in immunology,
Copied contents to your clipboard!